Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1211 | 8738 | 29.3 | 67% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 398 | 27726 | MULTIPLE MYELOMA//AMYLOIDOSIS//THALIDOMIDE |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 487 | 3323 | AMYLOIDOSIS//AL AMYLOIDOSIS//AMYLOIDOMA |
| 3342 | 1931 | TRANSTHYRETIN//FAMILIAL AMYLOIDOTIC POLYNEUROPATHY//FAMILIAL AMYLOID POLYNEUROPATHY |
| 5687 | 1521 | SERUM AMYLOID A//AMYLOID ENHANCING FACTOR//AA AMYLOID |
| 10440 | 997 | DIALYSIS RELATED AMYLOIDOSIS//DESTRUCTIVE SPONDYLOARTHROPATHY//DIALYSIS AMYLOIDOSIS |
| 14683 | 687 | UROONCOL PROGRAM//SERUM BETA2 MICROGLOBULIN//MOL UROL THER EUT PROGRAM |
| 28966 | 160 | SEMINAL VESICLE AMYLOIDOSIS//LOCALIZED AMYLOIDOSIS//MASSIVE HEMATURIA |
| 31723 | 119 | AMYLOID GOITER//AMYLOID GOITRE//AMORPHOUS DEPOSITS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AMYLOIDOSIS | Author keyword | 866 | 51% | 14% | 1220 |
| 2 | TRANSTHYRETIN | Author keyword | 689 | 64% | 8% | 666 |
| 3 | AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | Journal | 497 | 64% | 6% | 481 |
| 4 | FAMILIAL AMYLOIDOTIC POLYNEUROPATHY | Author keyword | 338 | 87% | 2% | 164 |
| 5 | FAMILIAL AMYLOID POLYNEUROPATHY | Author keyword | 228 | 81% | 2% | 137 |
| 6 | AL AMYLOIDOSIS | Author keyword | 203 | 71% | 2% | 163 |
| 7 | AMYLOIDOMA | Author keyword | 202 | 97% | 1% | 59 |
| 8 | CARDIAC AMYLOIDOSIS | Author keyword | 152 | 75% | 1% | 110 |
| 9 | AMYLOID TREATMENT PROGRAM | Address | 149 | 86% | 1% | 77 |
| 10 | SERUM AMYLOID A | Author keyword | 105 | 38% | 2% | 217 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AMYLOIDOSIS | 866 | 51% | 14% | 1220 | Search AMYLOIDOSIS | Search AMYLOIDOSIS |
| 2 | TRANSTHYRETIN | 689 | 64% | 8% | 666 | Search TRANSTHYRETIN | Search TRANSTHYRETIN |
| 3 | FAMILIAL AMYLOIDOTIC POLYNEUROPATHY | 338 | 87% | 2% | 164 | Search FAMILIAL+AMYLOIDOTIC+POLYNEUROPATHY | Search FAMILIAL+AMYLOIDOTIC+POLYNEUROPATHY |
| 4 | FAMILIAL AMYLOID POLYNEUROPATHY | 228 | 81% | 2% | 137 | Search FAMILIAL+AMYLOID+POLYNEUROPATHY | Search FAMILIAL+AMYLOID+POLYNEUROPATHY |
| 5 | AL AMYLOIDOSIS | 203 | 71% | 2% | 163 | Search AL+AMYLOIDOSIS | Search AL+AMYLOIDOSIS |
| 6 | AMYLOIDOMA | 202 | 97% | 1% | 59 | Search AMYLOIDOMA | Search AMYLOIDOMA |
| 7 | CARDIAC AMYLOIDOSIS | 152 | 75% | 1% | 110 | Search CARDIAC+AMYLOIDOSIS | Search CARDIAC+AMYLOIDOSIS |
| 8 | SERUM AMYLOID A | 105 | 38% | 2% | 217 | Search SERUM+AMYLOID+A | Search SERUM+AMYLOID+A |
| 9 | AA AMYLOIDOSIS | 95 | 64% | 1% | 94 | Search AA+AMYLOIDOSIS | Search AA+AMYLOIDOSIS |
| 10 | AMYLOID ENHANCING FACTOR | 91 | 94% | 0% | 32 | Search AMYLOID+ENHANCING+FACTOR | Search AMYLOID+ENHANCING+FACTOR |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PRIMARY SYSTEMIC AMYLOIDOSIS | 558 | 70% | 5% | 462 |
| 2 | SYSTEMIC AMYLOIDOSIS | 539 | 65% | 6% | 519 |
| 3 | AL AMYLOIDOSIS | 456 | 69% | 4% | 391 |
| 4 | SENILE SYSTEMIC AMYLOIDOSIS | 303 | 88% | 2% | 142 |
| 5 | LIGHT CHAIN AMYLOIDOSIS | 303 | 74% | 3% | 227 |
| 6 | PRE ALBUMIN | 292 | 77% | 2% | 197 |
| 7 | CARDIAC AMYLOIDOSIS | 236 | 61% | 3% | 253 |
| 8 | P COMPONENT | 186 | 60% | 2% | 201 |
| 9 | SAA | 165 | 63% | 2% | 167 |
| 10 | SECONDARY AMYLOIDOSIS | 162 | 73% | 1% | 125 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 497 | 64% | 6% | 481 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Medical progress - The systemic amyloidoses | 1997 | 550 | 66 | 80% |
| Serum amyloid A, the major vertebrate acute-phase reactant | 1999 | 507 | 282 | 64% |
| Amyloidosis: Pathogenesis and New Therapeutic Options | 2011 | 77 | 83 | 95% |
| Familial amyloid polyneuropathy | 2011 | 93 | 81 | 73% |
| The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug | 2012 | 69 | 156 | 74% |
| Amyloidosis | 2006 | 252 | 41 | 59% |
| Recent progress in the understanding and treatment of transthyretin amyloidosis | 2014 | 10 | 93 | 96% |
| Molecular mechanisms of amyloidosis | 2003 | 591 | 103 | 41% |
| The molecular biology and clinical features of amyloid neuropathy | 2007 | 140 | 62 | 90% |
| Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses | 2010 | 74 | 61 | 89% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AMYLOID TREATMENT PROGRAM | 149 | 86% | 0.9% | 77 |
| 2 | AMYLOIDOSIS | 133 | 66% | 1.4% | 122 |
| 3 | AMYLOID UNIT | 85 | 92% | 0.4% | 34 |
| 4 | AMYLOIDOSIS TREATMENT | 56 | 69% | 0.5% | 48 |
| 5 | SYL MOLLY PS | 37 | 74% | 0.3% | 28 |
| 6 | ESTUDOS PARAMILOIDOSE | 32 | 78% | 0.2% | 21 |
| 7 | CARDIAC AMYLOIDOSIS PROGRAM | 27 | 92% | 0.1% | 11 |
| 8 | AMYLOID TREATMENT | 21 | 75% | 0.2% | 15 |
| 9 | CARDIOL ANGIOL P MED | 19 | 74% | 0.2% | 14 |
| 10 | DIAGNOST MED | 13 | 16% | 0.9% | 76 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000015144 | POROKERATOSIS//DYSCHROMATOSIS SYMMETRICA HEREDITARIA//ACANTHOSIS NIGRICANS |
| 2 | 0.0000014134 | HAPTOGLOBIN//PENTRAXIN 3//PTX3 |
| 3 | 0.0000012436 | MULTIPLE MYELOMA//THALIDOMIDE//MYELOMA |
| 4 | 0.0000010206 | FAMILIAL MEDITERRANEAN FEVER//CHRONIC URTICARIA//MEFV |
| 5 | 0.0000004691 | ALZHEIMERS DISEASE//AMYLOID PRECURSOR PROTEIN//BETA AMYLOID |
| 6 | 0.0000004236 | SENESCENCE ACCELERATED MOUSE//SENESCENCE ACCELERATED MOUSE SAM//SAMP8 |
| 7 | 0.0000003828 | HEMODIALYSIS//BLOOD PURIFICATION//HAEMODIALYSIS |
| 8 | 0.0000003154 | CLUSTERIN//ELASTOFIBROMA//ELASTOFIBROMA DORSI |
| 9 | 0.0000003136 | SUBCOMMISSURAL ORGAN//REISSNERS FIBER//SCO SPONDIN |
| 10 | 0.0000003119 | ADVANCED GLYCATION END PRODUCTS//HMGB1//RAGE |